GAULT LAURA (Chief Medical Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/15/2024ACC: 0001562180-24-001337
Officer· Chief Medical Officer
Since Oct 2022
+33.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
33.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.25K
Price / share
—
Trade value
—
% of position
4955.9%
2/13/2024
227.00→11.48K
Total
Net shares
+11.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2024 | A · Award | +11.25K | — | — | 4955.9% | 227.00 | 11.48K |
| Total | +11.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
22.50K shares
Shares
+22.50K
Strike price
23.02
Held after
22.50K
Exercisable
—
2/13/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock22.50K shares | 2/13/2024 | A · Award | +22.50K | 23.02 | — | 22.50K |